Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walter E Haefeli

Showing results (1-10 of 351) with videos related to

Pageof 36
Sort By:
Deutsches Arzteblatt International|January 19, 2023
In ReplyWalter E Haefeli
The Annals of Pharmacotherapy|September 9, 2024
Comment on: Increased Theophylline Plasma Concentrations in a Patient With COVID-19Evelyn Krohmer, Walter E Haefeli
Pharmacy World & Science : PWS|January 12, 2010
Appropriateness of timing of drug administration in electronic prescriptionsArwa Hassan, Walter E Haefeli
Therapeutische Umschau. Revue Therapeutique|November 3, 2011
[Biologics - nomenclature and classification]Christine Eichbaum, Walter E Haefeli
Respiration; International Review of Thoracic Diseases|September 14, 2018
Plasma Drug Concentrations in Children Receiving Pulmonary Arterial Hypertension Combination TreatmentEkkehard Grünig, Walter E Haefeli
British Journal of Clinical Pharmacology|April 20, 2004
Genotyping of the A6986G polymorphism of CYP3A5Johanna Weiss, Walter E Haefeli
Therapeutische Umschau. Revue Therapeutique|September 30, 2008
[Particularities of drug dosing at the beginning and end of therapy]Walter E Haefeli, Ingeborg Walter-Sack
Gerontology|February 5, 2016
Age-Dependent Impact of Medication Underuse and Strategies for ImprovementAndreas D Meid, Walter E Haefeli
International Journal of Clinical Pharmacology and Therapeutics|October 30, 2018
Pill-count and the arithmetic of risk: Evidence that polypharmacy is a health status marker rather than a predictive surrogate for the risk of adverse drug eventsWalter E Haefeli, Andreas D Meid
Therapeutische Umschau. Revue Therapeutique|May 29, 2014
[Good prescribing practice]Hanna M Seidling, Walter E Haefeli
Pageof 36

Showing results (1-10 of 351) with videos related to

Sort By:
Pageof 36
Deutsches Arzteblatt International|January 19, 2023
In ReplyWalter E Haefeli
The Annals of Pharmacotherapy|September 9, 2024
Comment on: Increased Theophylline Plasma Concentrations in a Patient With COVID-19Evelyn Krohmer, Walter E Haefeli
Pharmacy World & Science : PWS|January 12, 2010
Appropriateness of timing of drug administration in electronic prescriptionsArwa Hassan, Walter E Haefeli
Therapeutische Umschau. Revue Therapeutique|November 3, 2011
[Biologics - nomenclature and classification]Christine Eichbaum, Walter E Haefeli
Respiration; International Review of Thoracic Diseases|September 14, 2018
Plasma Drug Concentrations in Children Receiving Pulmonary Arterial Hypertension Combination TreatmentEkkehard Grünig, Walter E Haefeli
British Journal of Clinical Pharmacology|April 20, 2004
Genotyping of the A6986G polymorphism of CYP3A5Johanna Weiss, Walter E Haefeli
Therapeutische Umschau. Revue Therapeutique|September 30, 2008
[Particularities of drug dosing at the beginning and end of therapy]Walter E Haefeli, Ingeborg Walter-Sack
Gerontology|February 5, 2016
Age-Dependent Impact of Medication Underuse and Strategies for ImprovementAndreas D Meid, Walter E Haefeli
International Journal of Clinical Pharmacology and Therapeutics|October 30, 2018
Pill-count and the arithmetic of risk: Evidence that polypharmacy is a health status marker rather than a predictive surrogate for the risk of adverse drug eventsWalter E Haefeli, Andreas D Meid
Therapeutische Umschau. Revue Therapeutique|May 29, 2014
[Good prescribing practice]Hanna M Seidling, Walter E Haefeli
Pageof 36